In 2023, the import of monoethanolamine to China stood at an estimated value of 63 million US Dollars. Forecasted values from 2024 to 2028 show a consistent upward trend, with average annual growth rates increasing year-on-year. Specifically, an estimated rise to 65.187 million USD in 2024 represents a roughly 3.5% increase from the previous year, followed by an approximate annual growth rate hovering around 3.2% to 3.3% through to 2028. The cumulative effect over five years translates to a compound annual growth rate (CAGR) of about 3.4%.
Future trends to watch for:
- Volatility in global chemical markets potentially impacting import costs and volumes.
- China's industrial demand shifts particularly in sectors like pharmaceuticals and personal care.
- Regulatory and policy changes in China affecting import tariffs and environmental standards.
- Technological advancements in production within China possibly reducing dependence on imports.
